Frontage Holdings Corp
HKEX:1521
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Berner Kantonalbank AG
SIX:BEKN
|
CH |
|
H
|
Harbour Energy PLC
LSE:HBR
|
UK |
|
Can Fin Homes Ltd
NSE:CANFINHOME
|
IN |
Frontage Holdings Corp
Stock-Based Compensation
Frontage Holdings Corp
Stock-Based Compensation Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Stock-Based Compensation | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Frontage Holdings Corp
HKEX:1521
|
Stock-Based Compensation
$2.6m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Stock-Based Compensation
$310m
|
CAGR 3-Years
0%
|
CAGR 5-Years
10%
|
CAGR 10-Years
10%
|
|
|
Danaher Corp
NYSE:DHR
|
Stock-Based Compensation
$298m
|
CAGR 3-Years
0%
|
CAGR 5-Years
10%
|
CAGR 10-Years
11%
|
|
|
Waters Corp
NYSE:WAT
|
Stock-Based Compensation
$54.1m
|
CAGR 3-Years
8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
5%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Stock-Based Compensation
$129m
|
CAGR 3-Years
1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
9%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Stock-Based Compensation
$247m
|
CAGR 3-Years
8%
|
CAGR 5-Years
21%
|
CAGR 10-Years
21%
|
|
Frontage Holdings Corp
Glance View
Frontage Holdings Corp. engages in the provision of research and analytical and development services throughout the drug discovery and development process. The company is headquartered in Exton, Pennsylvania. The company went IPO on 2019-05-30. Its segments include North America and the People’s Republic of China (PRC). Its North America segment, including laboratory testing, chemistry, manufacturing and control (CMC), preclinical research and chemistry services in the United States of America and Canada. Its PRC segment including laboratory testing, CMC, preclinical research, bioequivalence clinical and chemistry services in the PRC. Its preclinical research includes drug metabolism and pharmacokinetic (DMPK), safety, chemical and toxicology, and laboratory testing, including bioanalytical and biologics, and central laboratory. Its services and solutions include drug candidate evaluation, product development, clinical services and central laboratory and testing services.
See Also
What is Frontage Holdings Corp's Stock-Based Compensation?
Stock-Based Compensation
2.6m
USD
Based on the financial report for Dec 31, 2025, Frontage Holdings Corp's Stock-Based Compensation amounts to 2.6m USD.
What is Frontage Holdings Corp's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 5Y
23%
Over the last year, the Stock-Based Compensation growth was -18%. The average annual Stock-Based Compensation growth rates for Frontage Holdings Corp have been -18% over the past three years , 23% over the past five years .
